Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,075 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy

for
Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04870853

Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Sugar Land TX, Hattiesburg MS, Springdale AR,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05947851

Phase3, Recruiting

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Houston TX, Austin TX, San Antonio TX, Dallas TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 6 - 39

Code: NCT05702645

Recruiting

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

for
Infant, Extremely Premature, Obstetric Labor, Premature,
Location: Houston TX, San Antonio TX, Fort Worth TX, Mobile AL,
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 0 - 1

Code: NCT05685745

Recruiting

Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT05108519

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer

for
Stage 1 cT1b-T1cN0M0, Triple Negative Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06318897

Phase2, Recruiting

Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease

for
Degenerative Disc Disease, Disc Degeneration,
Location: Shenandoah TX, Tyler TX, Shreveport LA, New Orleans LA,
Sponsor: VIVEX Biologics, Inc.

Sex: All

Age: 22 - 70+

Code: NCT06778447

Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

for
Advanced Solid Tumors, HER2 Mutation
Location: Houston TX, Nashville TN, Fort Myers FL, Cleveland OH,
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06760819

Phase2, Recruiting

Understanding Patient Experience Among Asians at MD Anderson

for
Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06259253

Recruiting

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma,
Location: Houston TX, Cincinnati OH, Chicago IL, Columbus OH,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 39

Code: NCT05843253

Phase2, Recruiting

A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations

for
Metastatic Colorectal Cancer, KRAS G12C Mutations
Location: Houston TX, Boston MA
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06412198

Phase1, Phase2, Recruiting

QTX3034 in Patients With KRAS G12D Mutation

for
Solid Tumors
Location: Houston TX, San Antonio TX, Oklahoma City OK,
Sponsor: Quanta Therapeutics

Sex: All

Age: 18+

Code: NCT06227377

Phase1, Recruiting

Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.

for
Head and Neck Squamous Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06162377

Recruiting

Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics

for
Breast Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05056818

Recruiting

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

for
Crohn's Disease
Location: Houston TX, Webster TX, Cedar Park TX, Tyler TX,
Sponsor: Takeda

Sex: All

Age: 18 - 70

Code: NCT06045754

Recruiting

Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study

for
Acute Myeloid Leukemia (AML)
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06811233

Phase2, Recruiting

A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain

for
Brain Tumor
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05342454

Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

for
Heart Failure, Acute Heart Failure
Location: Houston TX, Austin TX, Dallas TX, Plano TX,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06008197

Phase3, Recruiting

Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

for
Aplastic Anemia, de Novo Myelodysplastic Syndrome,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT01624805

Phase2, Recruiting

Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer

for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Houston TX, Sugar Land TX, League City TX, Conroe TX,
Sponsor: NRG Oncology

Sex: Female

Age: 18+

Code: NCT06388018

Phase2, Recruiting